Unknown

Dataset Information

0

Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists.

ABSTRACT: Neuropeptide S (NPS) regulates various biological functions by activating the NPS receptor (NPSR). Previous studies demonstrated that the substitution of Gly(5) with d-amino acids generates NPSR antagonists. Eleven [d-Xaa(5)]NPS derivatives were synthesized and pharmacologically tested measuring [Ca(2+)](i) in HEK293(mNPSR) cells. The results confirmed that the [d-Xaa(5)] substitution promotes antagonist activity with potency inversely related to the side chain size and allowed identification of the novel potent NPSR peptide antagonist [(t)Bu-d-Gly(5)]NPS.

SUBMITTER: Guerrini R 

PROVIDER: S-EPMC2732566 | biostudies-literature | 2009 Jul

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists.

Guerrini Remo R   Camarda Valeria V   Trapella Claudio C   Caló Girolamo G   Rizzi Anna A   Ruzza Chiara C   Fiorini Stella S   Marzola Erika E   Reinscheid Rainer K RK   Regoli Domenico D   Salvadori Severo S  

Journal of medicinal chemistry 20090701 13

Neuropeptide S (NPS) regulates various biological functions by activating the NPS receptor (NPSR). Previous studies demonstrated that the substitution of Gly(5) with d-amino acids generates NPSR antagonists. Eleven [d-Xaa(5)]NPS derivatives were synthesized and pharmacologically tested measuring [Ca(2+)](i) in HEK293(mNPSR) cells. The results confirmed that the [d-Xaa(5)] substitution promotes antagonist activity with potency inversely related to the side chain size and allowed identification of  ...[more]

Similar Datasets

Unknown Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure neuropeptide S receptor antagonists.
| S-EPMC2653091 | biostudies-literature
Unknown Discovery of a Novel Class of Bicyclo[3.1.0]hexanylpiperazines as Noncompetitive Neuropeptide Y Y1 Antagonists.
| S-EPMC4025839 | biostudies-other
Unknown Discovery of benzothiazolylquinoline conjugates as novel human A3 receptor antagonists: biological evaluations and molecular docking studies.
| S-EPMC5830763 | biostudies-literature
Unknown Discovery of novel GPVI receptor antagonists by structure-based repurposing.
| S-EPMC4074120 | biostudies-literature
Unknown Discovery, optimization, and characterization of novel D2 dopamine receptor selective antagonists.
| S-EPMC4315423 | biostudies-literature
Unknown Discovery of heterobicyclic templates for novel metabotropic glutamate receptor subtype 5 antagonists.
| S-EPMC1973162 | biostudies-literature
Unknown Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists.
| S-EPMC2826142 | biostudies-literature
Unknown Discovery of Novel Glucagon Receptor Antagonists Using Combined Pharmacophore Modeling and Docking.
| S-EPMC6269551 | biostudies-literature
Unknown Discovery and Identification of Pyrazolopyramidine Analogs as Novel Potent Androgen Receptor Antagonists.
| S-EPMC6121070 | biostudies-literature
Unknown Discovery of benzimidazole oxazolidinediones as novel and selective nonsteroidal mineralocorticoid receptor antagonists.
| S-EPMC4416436 | biostudies-literature